Global Compliance Remains a Focus for Life Science Companies as Britain Negotiates Its Exit from the European Union

Portsmouth, NH, November 2, 2016– MMIS President and CEO Michaeline Daboul will be speaking at the CBI 3rd Annual Global Compliance Congress for Life Sciences, in London on November 16-17. “As Brexit continues, pharmaceutical and medical device companies must continue to improve relationships with healthcare providers and build strong, transparent compliance programs,” commented Ms. Daboul. “As governments continue to enforce anti-kickback laws it is critically important for companies to improve HCP engagement with robust compliance programs.”

Ms. Daboul, is scheduled to lead a session titled: A Case Study Approach to Improving HCP Engagement on Wednesday, November 16th at 11:15am. She is an industry expert and will be speaking to how life science companies are adopting new standards and best practices for enterprise compliance management while engaging with physicians. Through a case study approach, she will highlight:

  • How global health care laws and enforcement actions are driving increased communication with business stakeholder and internal monitoring by compliance and business teams;
  • Strategies to leverage or replace legacy systems to improve data collection and analysis of business processes in real-time;
  • Best practices and new standards to manage HCP engagement to ensure adherence to global laws, industry codes and company policies;
  • A case study on how a global device company has replaced legacy systems with MediSpend Global Compliance SaaS solutions to improve HCP engagement and comply with global laws.

MediSpend (www.medispend.com) is the first secure end-to-end software-as-a-service (SaaS) solution designed specifically to help pharmaceutical and medical device companies track and report HCP and HCO spend while simultaneously managing physician relationships

Ms. Daboul has been interviewed by Inside CMS, CIO Review, Healthcare Finance News, Mass Device and Healthcare Review North East Network on compliance challenges and the importance of implementing a global compliance process. CBI’s 3rd Global Compliance Congress for Life Sciences offers the opportunity for life sciences companies to come together, share ideas, network and learn from one another. 

-more-

Recently chosen by CIO Review for its annual listing of the 20 Most Promising Pharma and Life Science Technology Solution Providers, MMIS’s continues to break new ground with the first end-to-end compliance and data analytics SaaS solution, benefiting its customers around the globe.

For more information and to request a demo of the MediSpend Global Compliance Solutions, please visit www.medispend.com.

About MMIS

MMIS is a global technology company providing innovative compliance and business intelligence solutions for the life science industry. MMIS is a leading provider of cloud-based SaaS solutions dedicated to helping pharmaceutical, medical device and bio-pharmaceutical companies comply with global laws. The MediSpend Global Compliance Platform allows organizations to cost-effectively comply with the FCPA, anti-kickback and UK anti-bribery laws as well as global transparency laws securely across the globe.

Contact:

Taylor Ayoub

tayoub@medispend.com

(888) 731-7322 x8121

###